Replimune's drug for advanced skin cancer fails to win FDA nod again - Reuters
Replimune's drug for advanced skin cancer fails to win FDA nod again Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQV0xhbE5EbkRDa2l2OEdTdkhHRzlZU1cwdUM4bWt6ZGVTTWNIeFFUdHhDaW9SOHBiM3A3eV9VVTZoNXlRM0pNSk5adXJ1Vkw1SDZqSWI5aGlfT3B1VThsV21acFBVUU1RTE9oZXNSbHRMUlZTSzhNTGdXQTJELUgycm1QM0d5cGdQdlNicURjZEZ5LXVxa2t6MWh0aEI2N1o0UVM1X2VxMDAtb0t1T0pzSFdNTQ?oc=5" target="_blank">Replimune's drug for advanced skin cancer fails to win FDA nod again</a> <font color="#6f6f6f">Reuters</font>
The FDA declined to approve Replimune's RP1 drug for advanced skin cancer, citing insufficient data from studies, marking the second consecutive setback for the company.
The FDA declined to approve Replimune's RP1 drug for advanced skin cancer, citing insufficient data from studies, marking the second consecutive setback for the company.
The FDA declined to approve Replimune's RP1 drug for advanced skin cancer, citing insufficient data from studies, marking the second consecutive setback for the company.
The FDA declined to approve Replimune's RP1 drug for advanced skin cancer, citing insufficient data from studies, marking the second consecutive setback for the company.
The FDA declined to approve Replimune's RP1 drug for advanced skin cancer, citing insufficient data from studies, marking the second consecutive setback for the company.
Similar Stories
Related coverage based on topic and tags
Experimental treatments could help US Ebola patient - Reuters
Experimental treatments could help US Ebola patient Reuters
May 22, 2026 at 09:39 PMBundibugyo Ebola vaccines and treatments in development - Reuters
Bundibugyo Ebola vaccines and treatments in development Reuters
May 22, 2026 at 11:46 PMSinner struggles with illness, low energy as Cerundolo shocks French Open favourite in second round - Reuters
Sinner struggles with illness, low energy as Cerundolo shocks French Open favourite in second round Reuters
May 28, 2026 at 03:46 PMZuckerberg's philanthropic venture unveils AI world model for drug discovery - Reuters
Zuckerberg's philanthropic venture unveils AI world model for drug discovery Reuters
May 27, 2026 at 02:59 PMInvestors hunt for AI winners in small-cap US tech stocks - Reuters
Investors hunt for AI winners in small-cap US tech stocks Reuters
May 27, 2026 at 10:28 AMIn the shadow of Ebola: Scenes from the outbreak - Reuters
In the shadow of Ebola: Scenes from the outbreak Reuters
May 22, 2026 at 06:09 PM